Abstract
Should medicine developed through privately funded research be auctioned off to the highest bidder or distributed to those most in need? In this work of philosophical short story fiction, Amaya has developed a “bug” based on a rare flower that actively finds and repairs damaged cells in the human body. Her friend, and later husband, helps her bring additional funding to the project. The important flower is quite rare and after more than a decade Amaya is unable to replicate the flower’s properties. This puts her husband, and her investors, into a difficult situation of deciding if the neediest should get access to the limited treatments available, or if it should be auctioned off to the super rich. Amaya finally cracks the code and is able to replicate the flower’s properties when she dies in a mysterious lab explosion. Her daughter, Jayde, grows up fighting against selling the limited supply of medicine to the highest bidder. Over time, Jayde grows old and dies. At her funeral the truth is revealed to her husband, the company had her killed in order to perpetuate scarcity and secure increased profits.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
